Epidemic Haemorrhagic Fever

Fever, mucocutaneous haemorrhage, and severe headache during an epidemic of haemorrhagic fever.

Accepted 21 January 1998 A 36-year-old man developed moderate-grade fever, headache, and malaise. On the third day, he noticed purpuric skin lesions and sought medical opinion. Investigations revealed a platelet count of 57 x 109/l and haematocrit of 64%. Several people in his locality and the city had similar illness with reported deaths. A diagnosis was made and he was treated with antipyreti...

Dengue haemorrhagic fever

Factors increasing the risk of DHF outbreaks The occurrence of DHF outbreaks is linked to a number of factors, including the density of mosquito vectors, particularly that of Aedes aegypti. The precise population density of Ae. aegypti that is needed to sustain dengue virus transmission epidemically or endemically has yet to be determined, but experience in Singapore in recent years suggests th...

Ebola haemorrhagic fever

Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT, USA (H Feldmann MD); Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada (H Feldmann); and Department of Microbiology and Immunology, University of Texas Medical Branch and Galveston...

Ebola haemorrhagic fever.

Ebola viruses are the causative agents of a severe form of viral haemorrhagic fever in man, designated Ebola haemorrhagic fever, and are endemic in regions of central Africa. The exception is the species Reston Ebola virus, which has not been associated with human disease and is found in the Philippines. Ebola virus constitutes an important local public health threat in Africa, with a worldwide...

Dengue haemorrhagic fever